Cargando…

Tau Loss of Function, by Deletion or Aggregation, Contributes to Peripheral Insulin Resistance

BACKGROUND: Several epidemiological data revealed an association between Alzheimer’s disease (AD) and type 2 diabetes. Researchers concentrated on brain insulin resistance with little emphasis on the link between systemic insulin resistance and AD, despite the fact that the incidence of type 2 diabe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Lahham, Rabab, Mendez, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10578286/ https://www.ncbi.nlm.nih.gov/pubmed/37638441 http://dx.doi.org/10.3233/JAD-230392

Ejemplares similares

Tau deletion promotes brain insulin resistance
por: Marciniak, Elodie, et al.
Publicado: (2017)

Loss of presenilin function enhances tau phosphorylation and aggregation in mice
por: Soto-Faguás, Carlos M., et al.
Publicado: (2021)

Bacterial DNA promotes Tau aggregation
por: Tetz, George, et al.
Publicado: (2020)

Suppressing Tau Aggregation and Toxicity by an Anti-Aggregant Tau Fragment
por: Pir, Ghulam Jeelani, et al.
Publicado: (2018)

Peripheral administration of tau aggregates triggers intracerebral tauopathy in transgenic mice
por: Clavaguera, Florence, et al.
Publicado: (2013)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
por: Mamun, Abdullah Al, et al.
Publicado: (2020)

Propagation of Tau aggregates
por: Goedert, Michel, et al.
Publicado: (2017)

The 3-O sulfation of heparan sulfate proteoglycans contributes to the cellular internalization of tau aggregates
por: Ferreira, Andreia, et al.
Publicado: (2022)

Tau Post-translational Modifications: Dynamic Transformers of Tau Function, Degradation, and Aggregation
por: Alquezar, Carolina, et al.
Publicado: (2021)

Human tau pathology transmits glial tau aggregates in the absence of neuronal tau
por: Narasimhan, Sneha, et al.
Publicado: (2019)

Aging and high-fat diet feeding lead to peripheral insulin resistance and sex-dependent changes in brain of mouse model of tau pathology THY-Tau22
por: Kacířová, Miroslava, et al.
Publicado: (2021)

Deficient hippocampal insulin signaling and augmented Tau phosphorylation is related to obesity- and age-induced peripheral insulin resistance: a study in Zucker rats
por: Špolcová, Andrea, et al.
Publicado: (2014)

EGCG impedes human Tau aggregation and interacts with Tau
por: Sonawane, Shweta Kishor, et al.
Publicado: (2020)

Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro
por: Shin, Soo Jung, et al.
Publicado: (2020)

PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding
por: Soares, Alberto Carpinteiro, et al.
Publicado: (2021)

Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Hashimoto, Shoko, et al.
Publicado: (2019)

An acetylation–phosphorylation switch that regulates tau aggregation propensity and function
por: Carlomagno, Yari, et al.
Publicado: (2017)

Tau protein aggregation is associated with cellular senescence in the brain
por: Musi, Nicolas, et al.
Publicado: (2018)

Caspase-Mediated Truncation of Tau Potentiates Aggregation
por: Lee, Sangmook, et al.
Publicado: (2012)

Anti-aggregant tau mutant promotes neurogenesis
por: Joseph, Maria, et al.
Publicado: (2017)

Neem Derivatives Inhibits Tau Aggregation(1)
por: Gorantla, Nalini V., et al.
Publicado: (2019)

Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss
por: Straznicky, Nora E., et al.
Publicado: (2015)

Tau Phosphorylation, Aggregation, and Cell Toxicity
por: Avila, J., et al.
Publicado: (2006)

Are Tau Aggregates Toxic or Protective in Tauopathies?
por: Cowan, Catherine M., et al.
Publicado: (2013)

Structure-based inhibitors of tau aggregation
por: Seidler, PM, et al.
Publicado: (2017)

Signature of an aggregation-prone conformation of tau
por: Eschmann, Neil A., et al.
Publicado: (2017)

Pharmacological Modulators of Tau Aggregation and Spreading
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020)

The Significance of Tau Aggregates in the Human Brain
por: Castellani, Rudy J.
Publicado: (2020)

Cannabidiol Inhibits Tau Aggregation In Vitro
por: Alali, Soha, et al.
Publicado: (2021)

Neem Derivatives Inhibits Tau Aggregation
por: Gorantla, Nalini V., et al.
Publicado: (2021)

PE859, a Novel Tau Aggregation Inhibitor, Reduces Aggregated Tau and Prevents Onset and Progression of Neural Dysfunction In Vivo
por: Okuda, Michiaki, et al.
Publicado: (2015)

Potential synergy between tau aggregation inhibitors and tau chaperone modulators
por: Blair, Laura J, et al.
Publicado: (2013)

Of Loss and Tau
por: Garg, Divyani
Publicado: (2022)

Uptake of Polyelectrolyte Functionalized Upconversion Nanoparticles by Tau-Aggregated Neuron Cells
por: Song, Yo Han, et al.
Publicado: (2021)

Spreading of Tau Protein Does Not Depend on Aggregation Propensity
por: Rodrigues, Sara, et al.
Publicado: (2023)

Deletion of endogenous Tau proteins is not detrimental in Drosophila
por: Burnouf, Sylvie, et al.
Publicado: (2016)

Insulin resistance and obesity: how do they affect tau pathology?
por: Gratuze, Maud, et al.
Publicado: (2013)

Actin-binding protein filamin-A drives tau aggregation and contributes to progressive supranuclear palsy pathology
por: Tsujikawa, Koyo, et al.
Publicado: (2022)

Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation
por: Sonawane, Shweta Kishor, et al.
Publicado: (2021)

Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration
por: Briel, Nils, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lvqd81s73dnts1m0h67p1kt9h7